These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21147306)

  • 21. Anticonvulsant induced osteomalacia.
    Goraya JS; Gupta PN; Gupta RK; Bahadur R; Parmar VR
    Indian Pediatr; 2000 Mar; 37(3):325-9. PubMed ID: 10750079
    [No Abstract]   [Full Text] [Related]  

  • 22. Carbamazepine may trigger new-onset epileptic seizures in an individual with autism spectrum disorders: a case report.
    Monji A; Maekawa T; Yanagimoto K; Yoshida I; Hashioka S
    Eur Psychiatry; 2004 Aug; 19(5):322-3. PubMed ID: 15276670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute encephalopathy induced by oxcarbazepine and furosemide.
    Siniscalchi A; Mancuso F; Scornaienghi D; Ferreri G; De Sarro G
    Ann Pharmacother; 2004 Mar; 38(3):509-10. PubMed ID: 14970374
    [No Abstract]   [Full Text] [Related]  

  • 24. Generalized tonic-clonic seizures after acute oxcarbazepine withdrawal.
    Azar NJ; Wright AT; Wang L; Song Y; Abou-Khalil BW
    Neurology; 2008 May; 70(22 Pt 2):2187-8. PubMed ID: 18505998
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine.
    Azuma H; Negi A; Hattori M; Masayasu T; Akechi T; Furukawa TA
    Epilepsia; 2007 Oct; 48(10):1999-2001. PubMed ID: 17922775
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbamazepine-induced hyponatremia: assessment of risk factors.
    Kuz GM; Manssourian A
    Ann Pharmacother; 2005 Nov; 39(11):1943-6. PubMed ID: 16189283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocytic colitis in a pediatric patient: a possible adverse reaction to carbamazepine.
    Mahajan L; Wyllie R; Goldblum J
    Am J Gastroenterol; 1997 Nov; 92(11):2126-7. PubMed ID: 9362214
    [No Abstract]   [Full Text] [Related]  

  • 29. [Seizure exacerbation caused by antiepileptic drugs].
    Nakken KO; Johannessen SI
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2052-5. PubMed ID: 18846119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
    Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine induced bradycardia.
    Kaul S; Meena AK; Murthy JM
    Neurol India; 2000 Dec; 48(4):403-4. PubMed ID: 11146615
    [No Abstract]   [Full Text] [Related]  

  • 32. [Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants].
    Bayer A; Thiel HJ; Zrenner E; Paulus W; Ried S; Schmidt D
    Nervenarzt; 1995 Feb; 66(2):89-96. PubMed ID: 7715759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible precipitation of myoclonic seizures with oxcarbazepine.
    Kaddurah AK; Holmes GL
    Epilepsy Behav; 2006 Feb; 8(1):289-93. PubMed ID: 16356781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbamazepine-induced acute liver failure as part of the DRESS syndrome.
    Syn WK; Naisbitt DJ; Holt AP; Pirmohamed M; Mutimer DJ
    Int J Clin Pract; 2005 Aug; 59(8):988-91. PubMed ID: 16033627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Carbamazepine intoxication in a HIV patient under artiretroviral therapy].
    Beltrán-Marín I; Mauri-Lledrá JA; Letona-Carbajo S; Flamarique-Pascual A
    Med Clin (Barc); 2006 Oct; 127(13):517-8. PubMed ID: 17043009
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asthenozoospermia: possible association with long-term exposure to an anti-epileptic drug of carbamazepine.
    Hayashi T; Yoshinaga A; Ohno R; Ishii N; Kamata S; Watanabe T; Yamada T
    Int J Urol; 2005 Jan; 12(1):113-4. PubMed ID: 15661067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyponatremia associated with repeated use of levetiracetam.
    Nasrallah K; Silver B
    Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring.
    Azar NJ; Wang L; Song Y; Abou-Khalil BW
    Epilepsy Res; 2008 Mar; 79(1):78-83. PubMed ID: 18281195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.